Tectonic Therapeutic, Inc.’s TECX share price has dipped by 6.52%, which has investors questioning if this is right time to buy.

Septerna's GPCR platform shows promise, but execution risks, funding needs, and competition suggest caution. Click here to ...

G 蛋白偶联受体（GPCRs）是药物研发的重要靶点，但信号转导复杂阻碍了药物开发。研究人员探索了 GPCRs 的偏向性信号传导和细胞内调节剂，发现其在精准医学中具有潜在应用价值，有助于开发更安全有效的药物。 在生命科学和医学领域，药物研发一直是攻克 ...

No description, website, or topics provided.

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, May 12, 2025 - Addex Therapeutics (SIX/NASDAQ: ADXN), a ...

A novel GPS NMR method enabled precise tracking of motions within the β 1-adrenergic GPCR, revealing that the receptor exists in a dynamic equilibrium among inactive, preactive, and active states.

星形胶质细胞如何调节神经环路是神经生物学的基本问题。来自不同研究的人员利用果蝇、斑马鱼、小鼠等模型，研究星形胶质细胞 - 神经元通讯机制，发现 G 蛋白偶联肾上腺素能信号可 “门控” 星形胶质细胞对神经递质的反应，该机制或具普遍性，为相关 ...

Announced Global Collaboration with Novo Nordisk to Develop Oral Small Molecules for Metabolic Diseases with Over $2.2 Billion in Potential Milestone Payments On Track to Select a Next-Generation Oral ...

Using a method similar to the earth satellite GPS, they could track the motions of a GPCR and observe it in action. Their findings, recently published in Science , provide guidance for designing ...